CLASS II Device recall · Reported 20 May 2015 · FDA Enforcement Report

Vitek 2 AST-YS01 recalled by Biomerieux

Biomerieux is recalling Vitek 2 AST-YS01. The recall was initiated on 27 Mar 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codeslot 281317710, 26-AUG-15; lot 281347810, 22-JUN-16; and lot 281350120, 15-JUL-16.
Quantity recalled1604/20-card cartons

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1603-2015
FDA event ID
70868
Recalling firm
Biomerieux, Hazelwood, MO
Classification
Class II
Status
Terminated
Recall initiated
27 Mar 2015
FDA classified
12 May 2015
Reported
20 May 2015
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Mold

Timeline

27 Mar 2015Recall initiated by company
12 May 2015Classified by FDA+46 days
20 May 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The test kits have Out-of-Range-Low (OORL) Flucytosine QC results for Candida krusei ATCC 6258.

Product as listed by the FDA

Vitek 2 AST-YS01 REF 22 108, Fungal Susceptibility Card, 20 cards per carton, IVD. Intended for use with the Vitek 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of clinically significant yeasts to antifungal agents when used as instructed.

Where it was distributed

Distributed only to foreign subsidiaries and distributors, including Canada and Mexico.

Questions about this recall

Is Vitek 2 AST-YS01 recalled?

Yes. Biomerieux recalled Vitek 2 AST-YS01 on 27 Mar 2015. The recall is Class II and its status is Terminated. Recall number Z-1603-2015.

Why was it recalled?

The test kits have Out-of-Range-Low (OORL) Flucytosine QC results for Candida krusei ATCC 6258.

Which lots are affected?

lot 281317710, 26-AUG-15; lot 281347810, 22-JUN-16; and lot 281350120, 15-JUL-16.

Where was it sold?

Distributed only to foreign subsidiaries and distributors, including Canada and Mexico.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Biomerieux

All 476

Other Test Kits & Diagnostics recalls

All 2,656